Northern Trust Corp Iveric Bio, Inc. Transaction History

Northern Trust Corp

$600 Billion
Q3 2024

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 11, 2023	BUY	$26.24 - $39.63 $646,579 - $976,522	24,641 Added 1.89%	1,327,363 $52.2 Million
Q1 2023 May 15, 2023	BUY	$18.67 - $24.56 $726,636 - $955,875	38,920 Added 3.08%	1,302,722 $31.7 Million
Q4 2022 Feb 13, 2023	BUY	$17.24 - $23.95 $2.82 Million - $3.92 Million	163,795 Added 14.89%	1,263,802 $27.1 Million
Q3 2022 Nov 14, 2022	BUY	$9.4 - $18.59 $140,661 - $278,180	14,964 Added 1.38%	1,100,007 $19.7 Million
Q2 2022 Aug 12, 2022	BUY	$9.12 - $18.9 $272,925 - $565,601	29,926 Added 2.84%	1,085,043 $10.4 Million
Q1 2022 May 13, 2022	SELL	$12.15 - $16.83 $516,180 - $715,005	-42,484 Reduced 3.87%	1,055,117 $17.8 Million
Q4 2021 Feb 08, 2022	BUY	$13.83 - $18.78 $1.73 Million - $2.34 Million	124,791 Added 12.83%	1,097,601 $18.4 Million
Q3 2021 Nov 15, 2021	BUY	$7.07 - $17.5 $777,120 - $1.92 Million	109,918 Added 12.74%	972,810 $15.8 Million
Q2 2021 Aug 13, 2021	BUY	$5.69 - $7.17 $268,568 - $338,424	47,200 Added 5.79%	862,892 $5.45 Million
Q1 2021 May 12, 2021	SELL	$5.08 - $6.89 $258,145 - $350,122	-50,816 Reduced 5.86%	815,692 $5.04 Million
Q4 2020 Feb 11, 2021	SELL	$5.65 - $7.66 $11,390 - $15,442	-2,016 Reduced 0.23%	866,508 $5.99 Million
Q3 2020 Nov 16, 2020	BUY	$4.01 - $6.29 $1.45 Million - $2.28 Million	361,965 Added 71.46%	868,524 $4.9 Million
Q2 2020 Aug 14, 2020	BUY	$3.06 - $6.6 $1.33 Million - $2.87 Million	434,230 Added 600.35%	506,559 $2.58 Million
Q1 2020 May 14, 2020	BUY	$2.83 - $8.44 $21,171 - $63,139	7,481 Added 11.54%	72,329 $249,000
Q4 2019 Feb 14, 2020	SELL	$0.93 - $8.58 $20,628 - $190,312	-22,181 Reduced 25.49%	64,848 $556,000
Q2 2019 Aug 13, 2019	BUY	$1.21 - $1.48 $105,305 - $128,802	87,029 New	87,029 $114,000

Others Institutions Holding ISEE

# of Institutions

Shares Held

250K

Call Options Held

40K

Put Options Held

View Full List

About IVERIC bio, Inc.

Ticker ISEE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 118,078,000
Description
IVERIC bio, Inc., a biopharmaceutical company, discovers and develops novel treatments for retinal diseases with a focus on age-related and orphan inherited retinal diseases (IRDs). The company develops Zimura, an inhibitor of complement factor C5 comprising GATHER1, which has completed Phase 2/3 clinical trial; and GATHER2 that is in Phase 3 cl...

More about ISEE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Northern Trust Corp, based on Form 13F filings with the SEC.

News

Stay updated on Northern Trust Corp with notifications on news.

Account